This study suggested that MCP-1 promoted osteosarcoma migration through the CCR2 receptor and the upregulation of MMP-9 expression through c-Raf, MAPK, c-Jun, and AP-1 activation. The gene discussed is CCL2; the disease is osteosarcoma.